Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike.

Data is taken at the market close – at 4pm AEDT.

Stocks highlighted in yellow rose after making announcements.

Antisense Therapeutics (ASX:ANP) was the second-biggest winner, rising 60 per cent to 20c.

The mRNA-focused drug developer didn’t announce any news, but was the beneficiary of Morgans initiating coverage yesterday with a speculative buy rating and a 38c price target.

“While considerable trial risk and hurdles remain, we view ANP as one of the best risk/reward plays in the healthcare space given the data produced to date and heading into a catalyst rich 36 month period,” Morgans wrote.

The company is moving to a Phase 2b trial of its potential gene-silencing treatment for non-ambulant boys with Duchenne’s muscular dystrophy.

Kiwi cervical cancer diagnostic company TruScreen (ASX:TRU) advanced for a third day after listing on Wednesday.

On Friday TRU shares rose 57.1 per cent to 16.5.c, up 153 per cent from its 6.5c IPO price.